C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 249/12 (2006.01) A61K 31/4196 (2006.01) A61P 31/18 (2006.01)
Patent
CA 2574308
The present invention relates to a compounds according to formula (I), methods for treating diseases mediated by human immunodeficieny virus by administration of a compound according to formula (I) and pharmaceutical compositions for treating diseases mediated by human immunodeficieny virus containing a compound according to formula where R1, R2, R3, R4, R5, are as defined herein.
L'invention concerne un composé selon la formule (I), des méthodes de traitement de maladies induites par le virus de l'immunodéficience humaine consistant à administrer un composé selon la formule (I) et des compositions pharmaceutiques permettant de traiter des maladies induites par le virus de l'immunodéficience humaine renfermant un composé selon la formule dans laquelle R1, R2, R3, R4, R5 sont tels que définis dans la description.
Dunn James Patrick
Elworthy Todd Richard
Stefanidis Dimitrios
Sweeney Zachary Kevin
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Benzyltriazolone compounds as non-nucleoside reverse... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzyltriazolone compounds as non-nucleoside reverse..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzyltriazolone compounds as non-nucleoside reverse... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1466001